B cells and antibodies in CNS demyelinating disease

Journal of Neuroimmunology

Volumn 112, Issue 1-2, 2001, Pages 1-14

  Cross, Anne H ^a   Trotter, John L ^a   Lyons, Jeri Anne ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody; B cell; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Plasma cell

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; AUTOANTIBODY; COMPLEMENT; GANGLIOSIDE GD 1A; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; RETINA S ANTIGEN; TRANSALDOLASE;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; B LYMPHOCYTE; CEREBROSPINAL FLUID; GENE MUTATION; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; OPSONIZATION; PLASMA CELL; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIGEN PRESENTATION; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; B-LYMPHOCYTES; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MULTIPLE SCLEROSIS; PHAGOCYTOSIS; PLASMA CELLS;

EID: 0035212385     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00409-4     Document Type: Review

References (142)

1. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis
2. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses
3. Gamma-Globulin affinity for normal human tissue of the central nervous system
4. Acceleration of intracellular targeting of antigen by the B-cell receptor: Importance depends on the nature of the antigen-antibody interactions
5. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis
6. Multiple sclerosis: Cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid
7. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis
8. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions
9. CD80 and CD86 expression in multiple sclerosis patients: Clinical subtype specific variation in peripheral monocytes and B cells and lack of modulation by high dose methylprednisolone
10. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein
11. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients
12. A humoral response to oligodendrocyte-specific protein in MS: A potential molecular mimic
13. Cells of cerebrospinal fluid of multiple sclerosis patients secrete antibodies to myelin basic protein in vitro
14. MHC Class II antigen processing in B cells: Accelerated intracellular targeting of antigens
15. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis
16. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients
17. Immunocytochemical localization of the terminal complement complex in multiple sclerosis
18. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo
19. + T cells
20. Multiple sclerosis immune complexes: An analysis of component antigens and antibodies
21. Immunoblot detection of oligoclonal antimyelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis
22. Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin
23. Epitope-directed processing of specific antigen by B lymphocytes
24. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis
25. Expression of the murine complement regulatory protein Crry by glial cells and neurons
26. Antibodies to proteolipid apoprotein in chronic relapsing experimental allergic encephalomyelitis
27. Immunoglobulin-containing cells in multiple sclerosis plaques
28. Application of an immunoperoxidase method to a study of the central nervous system: Preliminary findings in a study of human formalin-fixed material
29. Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients
30. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis
31. Regulation of B-cell activation and antigen presentation by Fc receptors
32. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion
33. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help
34. Myelin/oligodendrocyte glycoprotein is a member of the immunoglobulin superfamily
35. Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats
36. Blood-brain barrier damage in acute multiple sclerosis plaques
37. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesions
38. Late complications of immune deviation therapy in a nonhuman primate
39. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate
40. Identification of autoantibodies associated with myelin damage in multiple sclerosis
41. Increased CD80+ B cells in active multiple sclerosis and reversal by interferon beta-1β therapy
42. The involvement of specific anti-myelin basic protein antibody-forming cells in multiple sclerosis immunopathology
43. Opsonization of normal myelin by anti-myelin antibodies an normal serum
44. Experimental allergic encephalomyelitis: Characterization of serum factors causing demyelination and swelling of myelin
45. An essential role for antibody in neutrophil and eosinophil recruitment to the cornea: B cell-deficient (μMT) mice fail to develop Th2-dependent, helminth-mediated keratitis
46. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein
47. B cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization
48. Induction of anergy in CD8 T cells by B cell presentation of antigen
49. Detection of serum antibody against arrestin from patients with acute disseminated encephalomyelitis
50. Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanisms for regulating CNS inflammation
51. Quantitative estimation of albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods
52. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis
53. The abnormal function of T cells in chronically anti-μ treated mice with no mature B-lymphocytes
54. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: Tissue entry and local retention of antigen-specific B cells
55. In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis: Antibody nature of the demyelinating factor and the role of complement
56. Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions
57. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
58. B lymphocytes producing demyelinating autoantibodies: Development and function in gene-targeted transgenic mice
59. FcγRII on human B cells can mediate enhanced antigen presentation
60. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
61. Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis
62. Retargeting T cell-mediated inflammation: A new perspective on autoantibody action
63. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis
64. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
65. B-cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide
66. Accumulation of plasma cells in inflamed sites: Effects of antigen, nonspecific microbial activators, and chronic inflammation
67. Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis
68. Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form
69. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a
70. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme
71. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains
72. Oligoclonal IgG in multiple sclerosis and subacute sclerosing panencephalitis brains
73. Oligoclonal IgG bands in plaques from multiple sclerosis brains
74. Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients
75. Immunogold localization and analysis of IgG during immune-mediated demyelination
76. Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids
77. Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice
78. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis
79. Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis
80. Circulating immune complexes in neurologic disease
81. Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients
82. Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: Exacerbations and remission
83. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis
84. Restricted use of VH4 germline segments in acute MS brain
85. Neuroimmunologic diseases: Effector cell responses and immunoregulatory mechanisms
86. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: Requirement for Lyt1+2+T lymphocytes
87. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
88. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis
89. The fine structure of chronically active multiple sclerosis
90. Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
91. Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions
92. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis
93. Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course
94. Clonal expansion and somatic hypermutation of Vh genes of B cells from cerebrospinal fluid in multiple sclerosis
95. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
96. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors
97. Immunoglobulins promote remyelination in the CNS
98. Multiple sclerosis. Cerebrospinal fluid immune complexes that bind Clq
99. Induction of anti-myelin antibodies in EAE and their possible role in demyelination
100. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigens to B cells: Evidence that the protective mechanisms depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells
101. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease
102. The expression of complement regulatory proteins by adult human oligodendrocytes
103. Intrathecal activation of the complement system and disability in multiple sclerosis
104. Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis
105. Importance of intrathecal synthesis of IgD in multiple sclerosis
106. Intrathecal immunoglobulin M synthesis in multiple sclerosis
107. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants
108. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis
109. Comparison of IgG heavy chain sequences in MS and SSPE brains reveals an antigen-driven response
110. EAE cerebrospinal fluid augments in vitro phagocytosis and metabolism of CNS myelin by macrophages
111. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis
112. B cells solicit their own help from T cells
113. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
114. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
115. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls
116. Humoral immune responses to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig
117. Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis
118. Human cerebrospinal fluid immunology
119. Opsonization with anti-myelin antibody increases the uptake and intracellular metabolism of myelin in inflammatory macrophages
120. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets
121. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages
122. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-α and nitric oxide
123. Chronic experimental allergic encephalomyelitis and antibody responses in rabbits immunized with bovine proteolipid apoprotein
124. Complement activation by isolated myelin: Activation of the classical pathway in the absence of myelin-specific antibodies
125. Dual implication of 2',3'-cyclic nucleotide 3 phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis
126. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis
127. Immunoglobulin G, A, and M-clonal restriction in multiple sclerosis cerebrospinal fluid and serum-analysis by two-dimensional electrophoresis
128. Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein
129. A correlation between cerebrospinal fluid myelin basic protein and antimyelin basic protein in multiple sclerosis patients
130. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients
131. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue
132. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid
133. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
134. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis
135. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis
136. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis
137. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice
138. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in the absence of antibody
139. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes
140. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls
141. A study of oligoclonal band negative multiple sclerosis
142. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies